Skip to main content

Eileen Margolies Raynor

Professor of Head and Neck Surgery & Communication Sciences
Pediatric Otolaryngology
Duke South Yellow Zone 4000, DUMC Box 3805, Durham, NC 27710
40 Duke Medicine Circle, Dukesouth Yellow Zone 4000, Durham, NC 27710

Overview


I am interested in multidisciplinary management of pediatric patients with an emphasis on minimizing anesthesia exposures and coordination of care.  I also focus on communication abilities including pediatric voice disorders working with voice therapists in the Duke Voice Care Center.  I enjoy congenital head and neck surgery as well as airway, endoscopic sinus and otology.  My research interests include collaborative projects with other disciplines and using technology to determine surgical outcomes.

Office Hours


Duke Otolaryngology of Raleigh: Mondays 8:30-4:00
Duke Childeren's Health Center (please contact 919-684-3834 for availability)

Current Duke Appointments & Affiliations


Professor of Head and Neck Surgery & Communication Sciences · 2025 - Present Pediatric Otolaryngology, Head and Neck Surgery & Communication Sciences
Professor in Pediatrics · 2025 - Present Pediatrics, Clinical Science Departments

Recent News Items


Published June 17, 2014
Jenna's Story

View All News Items

Recent Scholarly Works


Surgical Management of Pediatric Nodular Lymphocyte-Predominant Hodgkin's Lymphoma: A Systematic Review of Surgical Outcomes and Case Report.

Journal article Laryngoscope Investig Otolaryngol · December 2026 INTRODUCTION: Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype, representing 5% of Hodgkin lymphoma cases. It is distinguished by lymphocyte-predominant cells expressing CD20 and CD79a but not CD15 and CD30. Pediatric NLPHL affects ... Full text Link to item Cite

Evaluating speech dysfunction in patients with congenital cytomegalovirus - A multicenter retrospective study.

Journal article Int J Pediatr Otorhinolaryngol · April 2026 OBJECTIVE: Despite the known impact of congenital cytomegalovirus (cCMV) on hearing, implications on speech have been understudied. In the absence of hearing loss, 2% of cCMV patients may still develop speech and language impairment. This study will descri ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Otonexus OTO-06 (Novoscope)

Clinical TrialPrincipal Investigator · Awarded by OtoNexus Medical Technologies, Inc. · 2026 - 2031

Revolutionizing Pediatric Tonsillectomy Pharmacology and Therapeutics

ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024 - 2029

Clinical and host microbiome features in the development of acute otitis media

ResearchAdvisor · Awarded by National Institutes of Health · 2023 - 2028

View All Grants

Education


University of North Carolina, Chapel Hill · 1993 M.D.